These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36385418)

  • 1. Assessment of anti-nucleosome antibody (ANuA) isotypes for the diagnosis and prediction of systemic lupus erythematosus and lupus nephritis activity.
    Zeng Y; Xiao Y; Zeng F; Jiang L; Yan S; Wang X; Lin Q; Yu L; Lu X; Zhang Y; Lin Y
    Clin Exp Med; 2023 Sep; 23(5):1677-1689. PubMed ID: 36385418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of a high-avidity IgG ANAs for the diagnosis and activity prediction of systemic lupus erythematosus.
    Zeng Y; Lin Y; Wang X; Zhang Y; Peng F; Wang J; Jiang L; Liang S; Xiao Y
    Clin Rheumatol; 2020 Sep; 39(9):2619-2629. PubMed ID: 32189150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of IgG subclass anti-nuclear antibodies (ANAs) in systemic lupus erythematosus.
    Zeng Y; Zhang Y; Chen Q; Huang Q; Lin Y; Wang X; Wang JJ; Jiang L; Xiao Y
    Lupus; 2021 May; 30(6):901-912. PubMed ID: 33622075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease.
    Villalta D; Bizzaro N; Bassi N; Zen M; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
    PLoS One; 2013; 8(8):e71458. PubMed ID: 23951169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis.
    Förger F; Matthias T; Oppermann M; Becker H; Helmke K
    Lupus; 2004; 13(1):36-44. PubMed ID: 14870916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis.
    Bizzaro N; Villalta D; Giavarina D; Tozzoli R
    Autoimmun Rev; 2012 Dec; 12(2):97-106. PubMed ID: 22810055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Double-Stranded DNA Isotypes and Anti-C1q Antibody Improve the Diagnostic Specificity of Systemic Lupus Erythematosus.
    Jia Y; Zhao L; Wang C; Shang J; Miao Y; Dong Y; Zhao Z
    Dis Markers; 2018; 2018():4528547. PubMed ID: 30363714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine CXCL1 as a potential marker of disease activity in systemic lupus erythematosus.
    Zeng Y; Lin Q; Yu L; Wang X; Lin Y; Zhang Y; Yan S; Lu X; Li Y; Li W; Xiao Y
    BMC Immunol; 2021 Dec; 22(1):82. PubMed ID: 34961474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus.
    Su Y; Jia RL; Han L; Li ZG
    Clin Immunol; 2007 Jan; 122(1):115-20. PubMed ID: 17085075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the correlation between anti-ribosomal P protein antibody and systemic lupus erythematosus.
    Wang Y; Luo P; Guo T; Zou L; Shi J; Chen P
    Medicine (Baltimore); 2020 May; 99(20):e20192. PubMed ID: 32443340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
    Shang X; Ren L; Sun G; Yu T; Yao Y; Wang L; Liu F; Zhang L; He X; Liu M
    Immun Inflamm Dis; 2021 Jun; 9(2):407-418. PubMed ID: 33470559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis.
    Bruschi M; Moroni G; Sinico RA; Franceschini F; Fredi M; Vaglio A; Cavagna L; Petretto A; Pratesi F; Migliorini P; Locatelli F; Pazzola G; Pesce G; Bagnasco M; Manfredi A; Ramirez GA; Esposito P; Murdaca G; Negrini S; Cipriani L; Trezzi B; Emmi G; Cavazzana I; Binda V; Fenaroli P; Pisani I; Garibotto G; Montecucco C; Santoro D; Scolari F; Mosca M; Tincani A; Candiano G; Prunotto M; Volpi S; Verrina E; Angeletti A; Ravelli A; Ghiggeri GM
    Rheumatology (Oxford); 2021 Jul; 60(7):3176-3188. PubMed ID: 33374003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of immunity index and immunopathogenesis pattern of lupus nephritis patients.
    Gao JX; Diao HL; Liu YQ; Lv M; Dong H; Zhang XM; Wang YN
    J Biol Regul Homeost Agents; 2015; 29(1):201-6. PubMed ID: 25864759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CXCL13 chemokine serves as a potential biomarker to diagnose systemic lupus erythematosus with disease activity.
    Zeng Y; Zhang Y; Lin Y; Wang X; Chen Q; Huang Q; Wang J; Jiang L; Xiao Y
    Clin Exp Med; 2021 Nov; 21(4):611-619. PubMed ID: 33844093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
    Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
    Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary anti-nuclear antibody (ANA) mirrors serum ANA in systemic lupus erythematosus.
    Zhang T; Du Y; Wu Q; Li H; Nguyen T; Gidley G; Duran V; Goldman D; Petri M; Mohan C
    Arthritis Res Ther; 2022 Jan; 24(1):3. PubMed ID: 34980255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
    Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG, IgM, and IgA antinuclear antibodies in discoid and systemic lupus erythematosus patients.
    Jost SA; Tseng LC; Matthews LA; Vasquez R; Zhang S; Yancey KB; Chong BF
    ScientificWorldJournal; 2014; 2014():171028. PubMed ID: 24741342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and serological correlates of antinucleosome antibodies in South Africans with systemic lupus erythematosus.
    Tikly M; Gould T; Wadee AA; van der Westhuizen E; Mokgethwa BBN
    Clin Rheumatol; 2007 Dec; 26(12):2121-2125. PubMed ID: 17516129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.